Cargando…
Gastrointestinal risk factors and patient‐reported outcomes of ankylosing spondylitis in Korea
AIM: This study examined the degree of gastrointestinal (GI) risk and patient‐reported outcomes including GI‐related symptoms, adherence to non‐steroidal anti‐inflammatory drugs (NSAIDs), disease activity and quality of life (QoL) in patients with ankylosing spondylitis (AS). METHODS: Cross‐sectiona...
Autores principales: | Lee, Sang‐Hoon, Park, Yong‐wook, Choe, Jung‐Yoon, Shin, Kichul, Kwon, Seong‐Ryul, Cha, Jin‐Hye, Kim, Young‐Joo, Lee, Juneyoung, Kim, Tae‐Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065053/ https://www.ncbi.nlm.nih.gov/pubmed/31885217 http://dx.doi.org/10.1111/1756-185X.13758 |
Ejemplares similares
-
The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
por: Kwon, Seong-Ryul, et al.
Publicado: (2022) -
Cost-of-Illness and Quality of Life in Patients with Ankylosing Spondylitis at a Tertiary Hospital in Korea
por: Lee, Tae-Jin, et al.
Publicado: (2014) -
Characteristics of hip involvement in patients with ankylosing spondylitis in Korea
por: Jeong, Hyemin, et al.
Publicado: (2017) -
Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross‐sectional observational study
por: Lee, Sang‐Hoon, et al.
Publicado: (2022) -
Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab
por: Lee, Sang‐Hoon, et al.
Publicado: (2020)